Evidence map

ArticleThe New England journal of medicine2023

GLP-1 Receptor Agonist Orforglipron for Adults with Obesity. Reply.

Sean Wharton et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 38091543